<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Small case series have associated <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> with cerebral and spinal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> or <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, there has been no investigation of the frequency and etiology of neurovascular disorders in a large series of Marfan patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We conducted a retrospective, hospital-based study of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> patients seen in an 8-year period </plain></SENT>
<SENT sid="3" pm="."><plain>Records were reviewed in detail, and clinical characteristics of those with and without a neurovascular diagnosis compared </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of 513 patients, 18 (3.5%) had a neurovascular diagnosis, as follows: <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (11), <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> (2), <z:e sem="disease" ids="C0748902" disease_type="Disease or Syndrome" abbrv="">spinal cord infarction</z:e> (2), <z:hpo ids='HP_0100309'>subdural hematoma</z:hpo> (2), and spinal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (1) </plain></SENT>
<SENT sid="5" pm="."><plain>A cardioembolic source was identified in 12 of 13 patients with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, as follows: prosthetic heart valves (9), <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> (2), and <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (1) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy was a likely cause in 2 of 3 patients with hemorrhagic events </plain></SENT>
<SENT sid="7" pm="."><plain>Compared with other <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> patients, those with neurovascular events were older (39.6 versus 31.7 years, P=0.04) and more likely to be in <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (22.2% versus 3.2%, P=&lt;0.01), to have prosthetic heart valves (61.1% versus 7.7%, P=0.001), and to be taking <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy (72.2% versus 16.1%, P&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">Aortic disease</z:e>, a putative factor in the etiology of neurovascular complications, was present in equal measure in Marfan patients with and without neurovascular complications (78% versus 65%, P=NS) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Neurovascular complications of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> are rare during 8 years of follow-up, and generally are ischemic in nature </plain></SENT>
<SENT sid="10" pm="."><plain>A high-risk cardiac source was identified in the majority </plain></SENT>
<SENT sid="11" pm="."><plain>A significant association with vascular dissection was not established </plain></SENT>
</text></document>